Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.4K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Newly diagnosed high-risk localized prostate cancer after multiple [177Lu]Lu-PSMA radioligand therapy in the context of metastatic parotid carcinoma: a case report.

Journal of medical case reports·2026
Same author

Spectral dependence of lipofuscin fluorescence lifetimes revealed by FLIM with a superconducting nanowire single-photon detector.

Journal of biomedical optics·2026
Same author

The impact of high-grade complications on quality of life and psychosocial distress in the early period after radical cystectomy.

BJUI compass·2026
Same author

Magnetic resonance imaging of hand involvement in polymyalgia rheumatica: a comparison with seropositive rheumatoid arthritis.

RMD open·2026
Same author

Usage of a split CH2 domain as building block for new antibody formats.

Protein engineering, design & selection : PEDS·2026
Same author

Patient-reported outcomes: active surveillance vs radical therapies in low-risk prostate cancer.

BJU international·2026
Same journal

The Prevalence of Hospitalized Cases of Necrotizing Fasciitis: Anatomical Distribution, Amputations, and In-Hospital Mortality, 2019-2024.

Deutsches Arzteblatt international·2026
Same journal

Subclinical Atrial Fibrillation: Detection, Stroke Risk, and Treatment.

Deutsches Arzteblatt international·2026
Same journal

Fewer Premature Births After Assisted Reproduction.

Deutsches Arzteblatt international·2026
Same journal

Femoral Artery Pseudoaneurysm Due to Stent Fracture in PAOD.

Deutsches Arzteblatt international·2026
Same journal

Pain-Adapted Full Weight-bearing After Ankle Fracture Surgery: A Multicenter, Pragmatic, Single-armed Prospective Study.

Deutsches Arzteblatt international·2026
Same journal

Popliteal Artery Entrapment Syndrome.

Deutsches Arzteblatt international·2026
See all related articles

Related Experiment Video

Updated: Apr 3, 2026

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

1.4K

Detecting Prostate Cancer.

Marko Brock1, Christian von Bodman, Jüri Palisaar

  • 1Department of Urology, Marien-Hospital Herne, Ruhr-Universität Bochum, Radiologische Gemeinschaftpraxis, Herne.

Deutsches Arzteblatt International
|September 24, 2015
PubMed
Summary
This summary is machine-generated.

Magnetic resonance imaging (MRI) fusion-assisted targeted biopsy significantly improves prostate cancer detection rates, especially for clinically significant cancers, following previous negative biopsies. Systematic biopsy remains crucial, even with negative MRI findings, to ensure comprehensive cancer detection.

More Related Videos

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
05:35

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

2.2K
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

2.0K

Related Experiment Videos

Last Updated: Apr 3, 2026

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

1.4K
Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
05:35

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

2.2K
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

2.0K

Area of Science:

  • Urology
  • Radiology
  • Oncology

Background:

  • Prostate cancer diagnosis often relies on transrectal ultrasound (TRUS)-guided biopsy, which has a limited sensitivity of approximately 50%.
  • Fusion of magnetic resonance imaging (MRI) with TRUS allows for targeted biopsy of suspicious prostate lesions, potentially improving diagnostic accuracy.

Purpose of the Study:

  • To evaluate whether MRI/TRUS fusion-assisted targeted biopsy enhances the detection of prostate cancer compared to conventional methods.
  • To assess the detection rates of clinically significant prostate cancer using targeted versus systematic biopsy approaches.

Main Methods:

  • 168 men with suspected prostate cancer and prior negative biopsies underwent prostate MRI.
  • Suspicious lesions identified via MRI were biopsied using MRI/TRUS fusion-guided targeted biopsy.
  • A systematic biopsy of at least 12 cores was performed concurrently with the targeted biopsy.

Main Results:

  • Prostate cancer was detected in 42.3% of patients. The fusion-assisted targeted biopsy detected cancer in 19% of cases, while systematic biopsy detected it in 37.5%.
  • Targeted biopsy identified clinically significant cancer more frequently (84.4%) than systematic biopsy (65.1%).
  • Systematic biopsy alone detected cancer in 7 patients with normal MRI findings, highlighting its continued importance.

Conclusions:

  • MRI/TRUS fusion-assisted targeted biopsy is a valuable tool for improving prostate cancer detection in patients with prior negative biopsies.
  • While targeted biopsy excels at identifying clinically significant cancer, systematic biopsy should still be performed to maximize cancer detection, irrespective of MRI findings.